Atlas Trials

Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions

Clinical trial NCT07371182 · RECRUITING

Trial details

NCT number
NCT07371182
Sponsor
West China Second University Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Langerhans Cell Histiocytosis (LCH)
Start date
2026-06-19
Primary completion
2030-12-31
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.